በHouston፣ TX ለሉኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች
ለሉኬሚያ የሚደረጉ 28 ጥናቶች በHouston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Texas Children's Hospital, Houston
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Quetzal Site 6, Houston
Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 2
- M D Anderson Cancer Center, Houston
Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Texas Children's Hospital, Houston
- The Methodist Hospital, Houston
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The Methodist Hospital Research Institute, Houston
- The University of Texas MD Anderson Cancer Center, Houston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The University of Texas MD Anderson Cancer Center, Houston
A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
ተሳታዮችን በመፈለግ ላይደረጃ 2
- MD Anderson Cancer Center, Houston
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Houston
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Texas Children's Hospital, Houston
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- MD Anderson Cancer Center, Houston
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Texas, Houston
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1
- MD Anderson Cancer Center, Houston
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Baylor Texas Children's Hospital, Houston
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Houston
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of Texas MD Anderson Cancer Center, Houston
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Texas MD Anderson Cancer Center, Houston
CD4CAR for CD4+ Leukemia and Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- The University of Texas MD Anderson Cancer Center, Houston
A Study of Revumenib and Mezigdomide in People With Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- MD Anderson Cancer Center (Data Collection Only), Houston
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Dren Investigational Site, Houston
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- M D Anderson Cancer Center, Houston
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- M D Anderson Cancer Center, Houston
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- MD Anderson Cancer Center, Houston
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ተሳታዮችን በመፈለግ ላይደረጃ 1
- MD Anderson Cancer Center, Houston
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1
- The University of Texas MD Anderson Cancer Center, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, Houston
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
ተሳታዮችን በመፈለግ ላይደረጃ 1
- The University of Texas M.D. Anderson Cancer Center, Houston
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- MD Anderson Cancer Center, Houston
በሌሎች ከተሞች ለሉኬሚያ የሚደረጉ ጥናቶች
- Boston, MA25 ጥናቶች
- New York City, NY19 ጥናቶች
- Los Angeles, CA16 ጥናቶች
- Chicago, IL16 ጥናቶች
- Durham, NC13 ጥናቶች
- Columbus, OH12 ጥናቶች
- Baldwin Park, CA12 ጥናቶች
- Nashville, TN12 ጥናቶች
- Philadelphia, PA12 ጥናቶች
- Milwaukee, WI11 ጥናቶች
- Atlanta, GA11 ጥናቶች
- Seattle, WA11 ጥናቶች
በHouston ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር145 ጥናቶች
- የጡንቻ ካንሰር126 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)121 ጥናቶች
- Metastatic Cancer104 ጥናቶች
- የኮሎሬክታል ካንሰር102 ጥናቶች
- የእንቁላል ካንሰር89 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ85 ጥናቶች
- የሳንባ ካንሰር78 ጥናቶች
- የፕሮስቴት ካንሰር76 ጥናቶች
- የኤንዶሜትሪየም ካንሰር68 ጥናቶች
- የፓንክሪያስ ካንሰር61 ጥናቶች
- ሜላኖማ59 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።